Tenax Therapeutics (TENX) Other Working Capital Changes (2019 - 2022)
Tenax Therapeutics (TENX) posted quarterly Other Working Capital Changes of -$31152.0 for Q4 2022, down 24.08% year-over-year from -$41031.0 in Q4 2021, and down 2.02% on a QoQ basis from -$30535.0 in Q3 2022.
Tenax Therapeutics (TENX) Other Working Capital Changes (2019 - 2022) Analysis & Trends
Tenax Therapeutics has reported Other Working Capital Changes for 4 years, with the latest figure at -$31152.0 in Q4 2022.
- Other Working Capital Changes for Q4 2022 came in at -$31152.0, down 24.08% year-over-year; the trailing twelve-month figure through Dec 2023 was -$61687.0 (up 48.33% YoY), and the FY2022 annual result was -$119393.0, down 177.66% from the prior year.
- Other Working Capital Changes fell to -$31152.0 in Q4 2022, from -$30535.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $3.2 million in Q4 2025 and troughed at -$2.2 million in Q1 2026.
- A 5-year average of $131306.2 and a median of -$164796.0 in 2022 frame the typical range for Other Working Capital Changes.
- The widest annual swing landed in 2021, when Other Working Capital Changes soared 121.86%; it then slumped 533.65% in 2022.
- A 4-year view of Other Working Capital Changes shows it stood at -$25870.0 in 2019, then declined by 18.84% to -$30743.0 in 2020, then gained by 18.33% to -$25107.0 in 2021, then retreated by 24.08% to -$31152.0 in 2022.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were -$31152.0 in Q4 2022, -$30535.0 in Q3 2022, and -$29141.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.94 Bn | 132.09 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.59 Bn | 78.60 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.67 Bn | 60.49 Bn | 1.37 Bn |
| 4 | Moderna | 57.81 Bn | 52.67 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.25 Bn | 37.15 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.76 Bn | 28.45 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.41 Bn | 10.02 Bn | 668.28 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - |
| 10 | Tenax Therapeutics | 80.28 Mn | 80.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -31,152.00 |
| Dec 31, 2022 | -31,152.00 |
| Dec 31, 2022 | -31,152.00 |
| Sep 30, 2022 | -30,535.00 |
| Sep 30, 2022 | -30,535.00 |
| Sep 30, 2022 | -30,535.00 |
| Jun 30, 2022 | -29,141.00 |
| Jun 30, 2022 | -29,141.00 |
| Jun 30, 2022 | -29,141.00 |
| Mar 31, 2022 | -28,565.00 |
| Mar 31, 2022 | -28,565.00 |
| Mar 31, 2022 | -28,565.00 |
| Dec 31, 2021 | -25,107.00 |
| Dec 31, 2021 | -25,107.00 |
| Dec 31, 2021 | -25,107.00 |
| Sep 30, 2021 | -24,612.00 |
| Sep 30, 2021 | -24,612.00 |
| Sep 30, 2021 | -24,612.00 |
| Jun 30, 2021 | 6,720.00 |
| Jun 30, 2021 | 6,720.00 |